DEA schedule
Is Baqsimi a controlled substance?
Baqsimi contains glucagon. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Baqsimi (glucagon) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and glucagon is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Baqsimi?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 3 prescription listings from 2 labelers, none with a DEA schedule |
| DEA controlled substances list | glucagon is not on the list |
Baqsimi NDC listings
Questions
Is Baqsimi a controlled substance?
No. Baqsimi (glucagon) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and glucagon is not on the DEA controlled substances list.
Is Baqsimi a narcotic?
No. Baqsimi (glucagon) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Antihypoglycemic Agent and Gastrointestinal Motility Inhibitor.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Baqsimi
- What is Baqsimi used for?FDA label uses
- Generic for BaqsimiFDA Orange Book
- Is Glucagon a controlled substance?Federal schedule
- Generic for Gvoke HypoPenFDA Orange Book
- Generic for Gvoke KitFDA Orange Book
- Generic for Gvoke PFSFDA Orange Book
- Antihypoglycemic Agents listFDA drug class
- Gastrointestinal Motility Inhibitors listFDA drug class
- NDC 0548-8351Baqsimi NDC record
- NDC 0548-8352Baqsimi NDC record
- NDC 85766-212Baqsimi NDC record